Clinical Equivalence of Controlled-Release Oxycodone 20 mg and Controlled-Release Tramadol 200 mg after Surgery for Breast Cancer

Publisher： Karger

E-ISSN： 1423-0313|84|5|276-281

ISSN： 0031-7012

Source： Pharmacology, Vol.84, Iss.5, 2009-10, pp. : 276-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancement of the Controlled-Release Properties of Chitosan Membranes by Crosslinking with Suberoyl Chloride

By Chen Chao   Gao Zideng   Qiu Xiaoyun   Hu Shuwen  

Molecules, Vol. 18, Iss. 6, 2013-06 ,pp. : 7239-7252

MDPI

Access to resources Recommend Favorite

Multiple-Dose Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Subjects: A Comparison of Controlled-Release Sarpogrelate and Immediate-Release Sarpogrelate

By  

Pharmacology, Vol. 96, Iss. 1-2, 2015-06 ,pp. : 68-75

Karger

Access to resources Recommend Favorite

Chitosan-Genipin Microspheres for the Controlled Release of Drugs: Clarithromycin, Tramadol and Heparin

By Harris Ruth   Lecumberri Elena   Heras Angeles  

Marine Drugs, Vol. 8, Iss. 6, 2010-05 ,pp. : 1750-1762

MDPI

Access to resources Recommend Favorite

In Vitro Delivery and Controlled Release of Doxorubicin for Targeting Osteosarcoma Bone Cancer

By Kamba Shafiu Abdullahi   Ismail Maznah   Hussein-Al-Ali Samer Hasan   Ibrahim Tengku Azmi Tengku   Zakaria Zuki Abu Bakar  

Molecules, Vol. 18, Iss. 9, 2013-08 ,pp. : 10580-10598

MDPI

Access to resources Recommend Favorite

Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals

By Roach Paul   McGarvey David J.   Lees Martin R.   Hoskins Clare  

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 8585-8602

MDPI

Access to resources Recommend Favorite